The effect of C-terminal tyrosine phosphorylation on molecular motions in the Src kinases Hck and c-Src is investigated by molecular dynamics simulations. The SH2 and SH3 domains of the inactive kinases are seen to be tightly coupled by the connector between them, impeding activation. Dephosphorylation of the tail reduces the coupling between the SH2 and SH3 domains in the simulations, as does replacement of connector residues with glycine. A mutational analysis of c-Src expressed in Schizosaccharomyces pombe demonstrates that replacement of residues in the SH2-SH3 connector with glycine activates c-Src. The SH2-SH3 connector appears to be an inducible "snap lock" that clamps the SH2 and SH3 domains upon tail phosphorylation, but which allows flexibility when the tail is released.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0092-8674(01)00301-4DOI Listing

Publication Analysis

Top Keywords

sh2 sh3
16
sh3 domains
16
coupling sh2
8
c-terminal tyrosine
8
tyrosine phosphorylation
8
sh2-sh3 connector
8
dynamic coupling
4
sh2
4
sh3
4
domains
4

Similar Publications

While ATP-site inhibitors for protein-tyrosine kinases are often effective drugs, their clinical utility can be limited by off-target activity and acquired resistance mutations due to the conserved nature of the ATP-binding site. However, combining ATP-site and allosteric kinase inhibitors can overcome these shortcomings in a double-drugging framework. Here we explored the allosteric effects of two pyrimidine diamines, PDA1 and PDA2, on the conformational dynamics and activity of the Src-family tyrosine kinase Hck, a promising drug target for acute myeloid leukemia.

View Article and Find Full Text PDF
Article Synopsis
  • Adaptor proteins, particularly NCK1 and NCK2, play crucial roles in assembling molecular complexes and activating signaling pathways through their distinct SH2 and SH3 domains.* -
  • While it was previously thought that NCK1 and NCK2 were functionally redundant, emerging research shows they have unique roles in gene regulation, binding partners, and cellular functions.* -
  • The review discusses structural differences and modifications that contribute to their divergent characteristics, emphasizing the importance of differentiating between NCK1 and NCK2 in future research.*
View Article and Find Full Text PDF

Cocrystallization of the Src-Family Kinase Hck with the ATP-Site Inhibitor A-419259 Stabilizes an Extended Activation Loop Conformation.

Biochemistry

October 2024

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, 450 Technology Drive, Pittsburgh, Pennsylvania PA 15219, United States.

Hematopoietic cell kinase (Hck) is a member of the Src kinase family and is a promising drug target in myeloid leukemias. Here, we report the crystal structure of human Hck in complex with the pyrrolopyrimidine inhibitor A-419259, determined at a resolution of 1.8 Å.

View Article and Find Full Text PDF

The adaptor protein human GRB2 plays crucial roles in mediating signal transduction from cell membrane receptors to RAS and its downstream proteins by recruiting SOS1. Recent studies have revealed that GRB2 also serves as a scaffold for liquid-liquid phase separation (LLPS) with SOS1 and transmembrane receptors, which is thought to regulate the magnitude of cell signalling pathways. In this study, we employed solution NMR spectroscopy to investigate the interactions of the full-length GRB2 with proline-rich motifs (PRMs) derived from ten potential GRB2-binding sites in SOS1, as well as a peptide from a phosphorylation site of EGFR.

View Article and Find Full Text PDF

Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications.

Semin Cancer Biol

November 2024

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Otorhinolaryngology-Head and Neck Surgery, Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. Electronic address:

Article Synopsis
  • Phosphoinositide 3-kinase (PI3K) is a key enzyme that helps control important cellular functions like growth, survival, and metabolism by generating signaling molecules through the phosphorylation of phosphoinositides.
  • The enzyme is made up of a catalytic subunit (like p110α, p110β, or p110δ) and a regulatory subunit (p85), with PIK3R1 being a notable regulatory subunit that has different forms due to alternative splicing.
  • The review discusses how changes in PIK3R1 can affect cancer processes and treatment outcomes, highlighting the relevance of PIK3R1 mutations in cancer prognosis and the development of targeted therapies in precision medicine.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!